IP Library Granted Patent US 10,662,448
Granted Patent B2
US 10,662,448 · App. 15/679,825 · Granted May 26, 2020

Compositions and methods for producing lipids and other biomaterials from grain ethanol stillage and stillage derivatives

Inventors: Thomas W. Jeffries (Madison, WI); David Z. Mokry (Madison, WI); Christopher H. Calvey (Madison, WI)
Assignee: XYLOME CORPORATION
C12P7/649C12N1/16C12N15/81C12P7/6463C12P21/00C12Q1/48C12Q1/527C12N15/1096C12P7/06C12Q1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,662,448
App. No.
15/679,825
Granted
May 26, 2020
Kind
B2
Abstract

Lipogenic yeasts bioengineered to overexpress genes for lipid production, and methods of use thereof. The yeasts are modified to express, constitutively express, or overexpress an acetyl-CoA carboxylase, an alpha-amylase, an ATP citrate lyase, a diacylglycerol acyltransferase, a fatty acid synthase, a glycerol kinase, a 6-phosphogluconate dehydrogenase, a glycerol-3-phosphate dehydrogenase, a malic enzyme, a fatty acyl-CoA reductase, a delta-9 acyl-CoA desaturase, a glycerol-3-phosphate acyltransferase, a lysophosphatidate acyltransferase, a glucose-6-phosphate dehydrogenase, a beta-glucosidase, a hexose transporter, a glycerol transporter, a glycoside hydrolase enzyme, an auxiliary activity family 9 enzyme, or combinations thereof. The yeasts in some cases are also modified to reduce or ablate activity of certain proteins. The methods include cultivating the yeast to convert low value soluble organic stillage byproducts into lipids suitable for biodiesel production and other higher value uses.

Claims (28)

1. A recombinant yeast comprising one or more recombinant genes, wherein the one or more recombinant genes are configured to express:

a diacylglycerol acyltransferase;

a protein selected from the group consisting of a malic enzyme and a glycerol-3-phosphate acyltransferase; and

at least one of:

an acetyl-CoA carboxylase, wherein the acetyl-CoA carboxylase comprises a sequence at least about 90% identical to SEQ ID NO:2 and the acetyl-CoA carboxylase comprises a residue other than serine and threonine at a position corresponding to position 1146 of SEQ ID NO:2;

a glycerol-3-phosphate dehydrogenase comprising a sequence at least about 90% identical to SEQ ID NO:32;

a glucose-6-phosphate dehydrogenase and a 6-phosphogluconate dehydrogenase, wherein the glucose-6-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:44 and the 6-phosphogluconate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:30;

a fatty acid synthase, wherein the fatty acid synthase comprises a first subunit comprising a sequence at least about 90% identical to SEQ ID NO:22 and a second subunit comprising a sequence at least about 90% identical to SEQ ID NO:24;

an ATP citrate lyase, wherein the ATP citrate lyase comprises a first subunit comprising a sequence at least about 90% identical to SEQ ID NO:10 and a second subunit comprising a sequence at least about 90% identical to SEQ ID NO:12; and

a glycerol kinase and a glycerol-3-phosphate dehydrogenase, wherein the glycerol kinase comprises a sequence at least about 90% identical to SEQ ID NO:26 and the glycerol-3-phosphate dehydrogenase comprises a sequence at least about 90% identical to SEQ ID NO:56.

2. The recombinant yeast of claim 1 , wherein the diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:14 and is devoid of a sequence corresponding to positions 1-52 of SEQ ID NO:16.

3. The recombinant yeast of claim 2 , wherein the one or more recombinant genes are further configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:58.

4. The recombinant yeast of claim 1 , wherein the malic enzyme comprises a sequence at least about 90% identical to SEQ ID NO:34 and the glycerol-3-phosphate acyltransferase comprises a sequence at least about 90% identical to SEQ ID NO:40.

5. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the acetyl-CoA carboxylase.

6. The recombinant yeast of claim 5 , wherein the acetyl-CoA carboxylase comprises a serine or threonine at a position corresponding to position 639 of SEQ ID NO:2.

7. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the glycerol-3-phosphate dehydrogenase.

8. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the glucose-6-phosphate dehydrogenase and the 6-phosphogluconate dehydrogenase.

9. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the fatty acid synthase.

10. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the ATP citrate lyase.

11. The recombinant yeast of claim 1 , wherein the one or more recombinant genes are configured to express the glycerol kinase and the glycerol-3-phosphate dehydrogenase.

12. The recombinant yeast of claim 1 , wherein the yeast is a recombinant lipogenic yeast.

13. The recombinant yeast of claim 1 , wherein the yeast is a recombinant Lipomyces starkeyi.

14. A recombinant yeast comprising one or more recombinant genes, wherein:

the one or more recombinant genes are configured to express a diacylglycerol acyltransferase, wherein the diacylglycerol acyltransferase comprises a sequence at least 95% identical to SEQ ID NO:14 and is devoid of a sequence corresponding to positions 1-52 of SEQ ID NO:16;

the one or more recombinant genes are configured to express a second diacylglycerol acyltransferase, wherein the second diacylglycerol acyltransferase comprises a sequence at least 95% identical to SEQ ID NO:58;

the one or more recombinant genes are configured to express a malic enzyme comprising a sequence at least 95% identical to SEQ ID NO:34;

the one or more recombinant genes are configured to express a glycerol-3-phosphate acyltransferase comprising a sequence at least 95% identical to SEQ ID NO:40; and

the yeast is a recombinant Lipomyces starkeyi.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 2, 2024
From: XYLOME CORPORATION
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 068102/0155 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2017
From: JEFFRIES, THOMAS W.; CALVEY, CHRISTOPHER H.; MOKRY, DAVID Z.
To: XYLOME CORPORATION
Reel/Frame 043352/0087 →
Continuity (2)
Provisional Application 62409126 · Oct 17, 2016
Related Publication 20180245109A1 · Aug 30, 2018
Cited By (1)
US 12,350,364